Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001–2018
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0290994 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Harun Mazumder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Metabolic Syndrome, Breast Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study evaluated the prevalence, associated factors and trends in the prevalence of obesity-related cancer (ORC) among U.S. adults with metabolic syndrome (MetS) and age ≥20 years.
Methods
This study used cross-sectional data from the 2001–2018 National Health and Nutrition Examination Survey. The total period analyses included prevalence estimation, chi-square tests for comparing ORC vs non-ORC within subgroups, and a multivariable-logistic regression model to evaluate associated factors of ORC. For trend analysis, the total period was divided into three time periods: 2001–2006, 2007–2012 and 2013–2018. Age-standardized prevalence of ORC in each time period was calculated.
Results
The ORC prevalence was 35.8% representing 4463614 adults with MetS. A higher odds of ORC was observed among females (OR = 7.1, 95% CI = 4.9–10.3) vs males, Hispanic (OR = 2.9, 95% CI = 1.7–4.8) and non-Hispanic Black (OR = 2.7, 95% CI = 1.8–4) vs non-Hispanic White, age ≥60 (OR = 5.4, 95% CI = 1.9–15.4) vs age 20–39 years. Individual ORCs were thyroid (10.95%), breast (10%), uterine (9.18%), colorectal (7.86%), ovarian (5.74%), and stomach (0.80%). The age-standardized prevalence of ORC was observed stable in three time periods (30.6%, 30.3% and 30.7%). However, an increasing trend was seen for thyroid, uterine, colorectal and ovarian cancers while decreasing trend for breast cancer. Hispanic people showed a significant increasing trend of ORC (p = 0.004).
Conclusions
ORC was found significantly higher among female, Hispanic, non-Hispanic black and older people with MetS. The stable temporal trend of overall ORC, with an increasing trend in certain ORCs, makes the disease spectrum a public health priority. The findings imply the importance of intensifying efforts to reduce the burden of MetS comorbidities among U.S. adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh.
- School of Public Health, Louisiana State University Health Sciences Center-New Orleans, New Orleans, Louisiana, United States of America.
- Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
- International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
ORCID-Profile: Md Faruk Hossain, Sultan Mahmud
Zitieren
APA
Mazumder, H., Husain, M., Hossain, M. F., & Mahmud, S. (2023). Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001–2018. PLOS ONE. https://doi.org/10.1371/journal.pone.0290994
Vancouver
Mazumder H, Husain M, Hossain MF, Mahmud S. Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001–2018. PLOS ONE. 2023. doi:10.1371/journal.pone.0290994
BibTeX
@article{Mazumder2023,
author = {Mazumder, Harun and Husain, Maidul and Hossain, Md Faruk and Mahmud, Sultan},
title = {Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001–2018},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0290994}
}
EUVIMED